Carregant...
SELIMETRY—a multicentre I-131 dosimetry trial: a clinical perspective
Treatment options for patients with thyroid cancer that is no longer sensitive to iodine therapy are limited. Those treatments which currently exist are associated with significant toxicity. The SELIMETRY trial (EudraCT No 2015-002269-47) aims to investigate the role of the MEK inhibitor Selumetinib...
Guardat en:
| Publicat a: | Br J Radiol |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The British Institute of Radiology.
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5605100/ https://ncbi.nlm.nih.gov/pubmed/28291381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1259/bjr.20160637 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|